200
Participants
Start Date
December 1, 2021
Primary Completion Date
February 29, 2024
Study Completion Date
February 29, 2024
not required
This a multicenter, prospective, non-randomized, single-arm, open label clinical study. This design doesn't include control vs intervention arms
San Raffaele Hospital, Milan
Azienda Ospedaliera Universitaria Federico II,, Napoli
Fondazione Policlinico Universitario A. Gemelli IRCCS,, Roma
Advice Pharma Group srl
INDUSTRY
IRCCS San Raffaele
OTHER